S. Zelenitsky, G. Harding, and S. Sun, Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis, Journal of Antimicrobial Chemotherapy, vol.52, issue.4, pp.668-74, 2003.
DOI : 10.1093/jac/dkg403

C. Roger, B. Nucci, and B. Louart, Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis, Journal of Antimicrobial Chemotherapy, vol.71, issue.1, 2015.
DOI : 10.1093/jac/dkv291

N. Allou, A. J. Levy, and Y. , Assessment of the National French recommendations regarding the dosing regimen of 8 mg/kg of gentamicin in patients hospitalized in intensive care unit, Anaesth Crit Care Pain Med, 2016.

J. Kumazawa, The history of antibiotics: The Japanese story, Journal of Infection and Chemotherapy, vol.8, issue.2, pp.125-133, 2002.
DOI : 10.1007/s101560200022

. Karlowsky, Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro, J antimicrob Chemother, vol.33, pp.937-979, 1994.

K. Shannon, Mechanisms of resistance to aminoglycosides in clinical isolates, Journal of Antimicrobial Chemotherapy, vol.9, issue.2
DOI : 10.1093/jac/9.2.91

E. Center-for-disease-prevention and . Control, Antimicrobial resistance surveillance in Europe, Disponible sur, 2012.

. Schmitz, Prevalence of Aminoglycoside Resistance in 20 European University Hospitals Participating in the European SENTRY Antimicrobial Surveillance Programme, European Journal of Clinical Microbiology & Infectious Diseases, vol.18, issue.6, pp.414-435, 1999.
DOI : 10.1007/s100960050310

V. Dubois, ??-Lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres), Journal of Antimicrobial Chemotherapy, vol.62, issue.2, pp.316-339, 2008.
DOI : 10.1093/jac/dkn174

W. Dager, Aminoglycoside Pharmacokinetics: Volume of Distribution in Specific Adult Patient Subgroups, Annals of Pharmacotherapy, vol.22, issue.7-8, pp.7-8944, 1994.
DOI : 10.1097/00007691-198911040-00011

. Moore, Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory Concentration, Journal of Infectious Diseases, vol.155, issue.1, pp.93-102, 1987.
DOI : 10.1093/infdis/155.1.93

M. Paul, ?lactam monotherapy versus ?lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials, BMJ, 2004.

. Galloe, Aminoglycosides: single or multiple daily dosing?, European Journal of Clinical Pharmacology, vol.48, issue.1, pp.39-43, 1995.
DOI : 10.1007/BF00202170

. Blaser, Once-daily dosing of aminoglycosides, European Journal of Clinical Microbiology & Infectious Diseases, vol.17, issue.Supplement 3, pp.1029-1067, 1995.
DOI : 10.1007/BF01590935

. Hatala, Once-Daily Aminoglycoside Dosing in Immunocompetent Adults, Annals of Internal Medicine, vol.124, issue.8, pp.717-742, 1996.
DOI : 10.7326/0003-4819-124-8-199604150-00003

. Barza, Single or multiple daily doses of aminoglycosides: a meta- analysis, BMJ, vol.312, issue.7027, pp.338-383, 1996.
DOI : 10.1136/bmj.312.7027.338

. Ferriols-lisart, Effectiveness and safety of once daily aminoglycosides: a metaanalysis, Am J Health Syst Pharm, vol.53, pp.1141-50, 1996.

. Munckhof, A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses, Journal of Antimicrobial Chemotherapy, vol.37, issue.4, pp.645-63, 1996.
DOI : 10.1093/jac/37.4.645

. Bailey, A Meta-Analysis of Extended-Interval Dosing Versus Multiple Daily Dosing of Aminoglycosides, Clinical Infectious Diseases, vol.24, issue.5, pp.786-95, 1997.
DOI : 10.1093/clinids/24.5.786

. Hatala, Single Daily Dosing of Aminoglycosides in Immunocompromised Adults: A Systematic Review, Clinical Infectious Diseases, vol.24, issue.5, pp.810-815, 1997.
DOI : 10.1093/clinids/24.5.810

S. Croes, Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring, European Journal of Pharmaceutical Sciences, vol.45, issue.1-2, 2012.
DOI : 10.1016/j.ejps.2011.10.022

. Marick, A prospective randomized study comparing once- versos twice-daily amikadn dosing in critically ill adult and paediatric patients, Journal of Antimicrobial Chemotherapy, vol.28, issue.5, pp.753-64, 1991.
DOI : 10.1093/jac/28.5.753

. Fantin, Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis., Antimicrobial Agents and Chemotherapy, vol.34, issue.12, pp.2387-91, 1990.
DOI : 10.1128/AAC.34.12.2387

. Maller, Once- versus twice-daily amikacin regimen: efficacy and safety in systemic Gram-negative infections, Journal of Antimicrobial Chemotherapy, vol.31, issue.6, pp.939-987, 1993.
DOI : 10.1093/jac/31.6.939

O. Shea, Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate? Semin Dial, pp.225-255, 2009.

. Traynor, Aminoglycoside dosing weight correction factors for patients of various body sizes, Antimicrobial Agents and Chemotherapy, vol.39, issue.2, pp.545-593, 1995.
DOI : 10.1128/AAC.39.2.545

. Rybak, Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity, Antimicrob Agents Chemother, vol.43, pp.1549-55, 1999.

W. Duszynska, Therapeutic drug monitoring of amikacin in septic patients, Critical Care, vol.17, issue.4, p.165, 2013.
DOI : 10.1086/520991

J. Goncalves-pereira, Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose, Clinical Microbiology and Infection, vol.16, issue.8, pp.1258-63, 2010.
DOI : 10.1111/j.1469-0691.2009.03074.x

S. Buijk, Experience with a once-daily dosing program of aminoglycosides in critically ill patients, Intensive Care Medicine, vol.28, issue.7, pp.936-978, 2002.
DOI : 10.1007/s00134-002-1313-7

C. Roger, Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations, International Journal of Antimicrobial Agents, vol.46, issue.1, 2015.
DOI : 10.1016/j.ijantimicag.2015.02.009

D. Demczar, Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing, Antimicrob Agents Chemother, vol.41, pp.1115-1124, 1997.

R. Rea, Suboptimal Aminoglycoside Dosing in Critically Ill Patients, Therapeutic Drug Monitoring, vol.30, issue.6, pp.674-81, 2008.
DOI : 10.1097/FTD.0b013e31818b6b2f

J. Phillips, Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia, Internal Medicine Journal, vol.80, issue.1, pp.23-29, 2001.
DOI : 10.1093/jac/42.1.103

E. De-montmollin, Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25??mg/kg total body weight regimen, Intensive Care Medicine, vol.33, issue.7, pp.998-1005, 2014.
DOI : 10.1007/s00134-014-3276-x

F. Taccone, Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock, Critical Care, vol.14, issue.2, p.53, 2010.
DOI : 10.1186/cc8945

J. Marmuse and A. P. , Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis, Crit Care, vol.19, issue.2, p.70, 2015.

J. Bertino, Incidence of and Significant Risk Factors for Aminoglycoside-Associated Nephrotoxicity in Patients Dosed by Using Individualized Pharmacokinetic Monitoring, Journal of Infectious Diseases, vol.167, issue.1, pp.173-182, 1993.
DOI : 10.1093/infdis/167.1.173

J. Oliveira, Prevalence and Risk Factors for Aminoglycoside Nephrotoxicity in Intensive Care Units, Antimicrobial Agents and Chemotherapy, vol.53, issue.7, pp.2887-91, 2009.
DOI : 10.1128/AAC.01430-08

L. Blackburn, First-dose pharmacokinetics of aminoglycosides in critically ill haematological malignancy patients, International Journal of Antimicrobial Agents, vol.45, issue.1, pp.46-53, 2015.
DOI : 10.1016/j.ijantimicag.2014.09.006

A. Schneider, Electronic bed weighing vs daily fluid balance changes after cardiac surgery, Journal of Critical Care, vol.28, issue.6, pp.1113-1114, 2013.
DOI : 10.1016/j.jcrc.2013.07.056